Form 4 Tracker
Adaptive Biotechnologies Corp
ADPT

42 insider filings · Latest: Apr 27, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Feb 2, 2026Feb 5 12:37 AMChad M RobinsDirector, CEO and Chairman
Sale
124,998$18.44$2.3M2,459,245(D)

View →

Feb 3, 2026Feb 3 10:09 PMHarlan Robins
Proposed Sale
8,120$18.50$150.2K

View →

Feb 2, 2026Feb 2 10:26 PMHarlan Robins
Proposed Sale
34,668$18.39$637.5K

View →

Feb 2, 2026Feb 2 10:24 PMChad Robins
Proposed Sale
124,998$18.39$2.3M

View →

Jan 12, 2026Jan 12 9:27 PMFRANCIS LO
Proposed Sale
64,293$15.76$1.0M

View →

Jan 12, 2026Jan 12 9:26 PMKYLE PISKEL
Proposed Sale
11,081$15.76$174.6K

View →

Jan 6, 2026Jan 6 9:57 PMHarlan Robins
Proposed Sale
10,000$16.11$161.1K

View →

Jan 5, 2026Jan 5 11:22 PMChad Robins
Proposed Sale
124,998$16.17$2.0M

View →

Dec 15, 2025Dec 15 9:24 PMFRANCIS LO
Proposed Sale
136,706$15.44$2.1M

View →

Dec 10, 2025Dec 10 9:03 PMROBERT M HERSHBERG
Proposed Sale
22,968$16.00$367.5K

View →

Dec 4, 2025Dec 4 10:15 PMHarlan Robins
Proposed Sale
10,000$17.46$174.6K

View →

Dec 4, 2025Dec 4 9:38 PMSHARON BENZENO
Proposed Sale
12,604$17.13$215.9K

View →

Dec 3, 2025Dec 3 10:58 PMHarlan Robins
Proposed Sale
27,212$17.13$466.1K

View →

Dec 1, 2025Dec 1 11:03 PMChad Robins
Proposed Sale
124,998$18.84$2.4M

View →

Nov 28, 2025Nov 28 6:18 PMKYLE PISKEL
Proposed Sale
162,820$19.72$3.2M

View →

Nov 26, 2025Nov 26 10:30 PMChad Robins
Proposed Sale
35,736$19.72$704.7K

View →

Nov 21, 2025Nov 24 9:58 PMBENZENO SHARON
Proposed Sale
308,477$16.32$5.0M

View →

Nov 21, 2025Nov 21 9:45 PMSHARON BENZENO
Proposed Sale
308,837$16.32$5.0M

View →

Nov 20, 2025Nov 20 9:25 PMSHARON BENZENO
Proposed Sale
201,993$15.15$3.1M

View →

Nov 19, 2025Nov 19 9:22 PMSHARON BENZENO
Proposed Sale
95,932$13.75$1.3M

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Mar 3, 2026Mar 6 12:42 AMJulie RubinsteinPresident and COO
Option Exercise
26,603$12.14451,463(D)

View →

Feb 4, 2026Feb 7 12:30 AMKyle PiskelChief Financial Officer
Option Exercise
2,145$12.142,146(D)

View →

← Previous

Page 3 of 3